Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1986 1
1988 1
1991 1
1994 1
1996 1
1997 1
1998 3
1999 2
2000 1
2002 2
2003 1
2004 1
2005 3
2007 2
2009 2
2010 3
2011 3
2012 7
2013 3
2014 11
2015 12
2016 19
2017 10
2018 13
2019 15
2020 17
2021 25
2022 21
2023 27
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20JS, 5BAuthor
Page 1
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, Lacombe V, Terriou L, Ardois S, Bouaziz JD, Mathian A, Le Guenno G, Aouba A, Outh R, Meyer A, Roux-Sauvat M, Ebbo M, Zhao LP, Bigot A, Jamilloux Y, Guillotin V, Flamarion E, Henneton P, Vial G, Jachiet V, Rossignol J, Vinzio S, Weitten T, Vinit J, Deligny C, Humbert S, Samson M, Magy-Bertrand N, Moulinet T, Bourguiba R, Hanslik T, Bachmeyer C, Sebert M, Kostine M, Bienvenu B, Biscay P, Liozon E, Sailler L, Chasset F, Audemard-Verger A, Duroyon E, Sarrabay G, Borlot F, Dieval C, Cluzeau T, Marianetti P, Lobbes H, Boursier G, Gerfaud-Valentin M, Jeannel J, Servettaz A, Audia S, Larue M, Henriot B, Faucher B, Graveleau J, de Sainte Marie B, Galland J, Bouillet L, Arnaud C, Ades L, Carrat F, Hirsch P, Fenaux P, Fain O, Sujobert P, Kosmider O, Mekinian A; French VEXAS group; GFEV, GFM, CEREMAIA, MINHEMON. Georgin-Lavialle S, et al. Br J Dermatol. 2022 Mar;186(3):564-574. doi: 10.1111/bjd.20805. Epub 2021 Nov 28. Br J Dermatol. 2022. PMID: 34632574 Free article.
Randomized Controlled Trial of Surgical Rib Fixation to Nonoperative Management in Severe Chest Wall Injury.
Meyer DE, Harvin JA, Vincent L, Motley K, Wandling MW, Puzio TJ, Moore LJ, Cotton BA, Wade CE, Kao LS. Meyer DE, et al. Ann Surg. 2023 Sep 1;278(3):357-365. doi: 10.1097/SLA.0000000000005950. Epub 2023 Jun 15. Ann Surg. 2023. PMID: 37317861 Clinical Trial.
Quality of life at 1, 3, and 6 months was measured using the EQ-5D-5L survey. RESULTS: Eighty-four patients were randomized in an intention-to-treat analysis (usual care = 42, SSRF = 42). ...At 1 month, SSRF patients had greater impairment in mobility [3 (2-3) vs 2 (1-2), …
Quality of life at 1, 3, and 6 months was measured using the EQ-5D-5L survey. RESULTS: Eighty-four patients were randomized in an int …
Virtual Reality for Upper Limb Rehabilitation in Subacute and Chronic Stroke: A Randomized Controlled Trial.
Kiper P, Szczudlik A, Agostini M, Opara J, Nowobilski R, Ventura L, Tonin P, Turolla A. Kiper P, et al. Arch Phys Med Rehabil. 2018 May;99(5):834-842.e4. doi: 10.1016/j.apmr.2018.01.023. Epub 2018 Feb 14. Arch Phys Med Rehabil. 2018. PMID: 29453980 Clinical Trial.
INTERVENTIONS: The experimental treatment was based on the combination of RFVE with CR, whereas control treatment was based on the same amount of CR. Both treatments lasted 2 hours daily, 5d/wk, for 4 weeks. MAIN OUTCOME MEASURES: Fugl-Meyer upper extremity scale (F …
INTERVENTIONS: The experimental treatment was based on the combination of RFVE with CR, whereas control treatment was based on the same amou …
Mapping EQ-5D-3L to EQ-5D-5L.
van Hout BA, Shaw JW. van Hout BA, et al. Value Health. 2021 Sep;24(9):1285-1293. doi: 10.1016/j.jval.2021.03.009. Epub 2021 May 18. Value Health. 2021. PMID: 34452708 Free article.
OBJECTIVES: The original 3-level EQ-5D (EQ-5D-3L) includes 5 dimensions with 3 levels of problems per dimension. ...The objective of this research was to develop a mapping function to link EQ-5D-3L responses to value sets for the EQ-5D-5L. METHODS: Var …
OBJECTIVES: The original 3-level EQ-5D (EQ-5D-3L) includes 5 dimensions with 3 levels of problems per dimension. ...The object …
Mirror therapy enhances motor performance in the paretic upper limb after stroke: a pilot randomized controlled trial.
Samuelkamaleshkumar S, Reethajanetsureka S, Pauljebaraj P, Benshamir B, Padankatti SM, David JA. Samuelkamaleshkumar S, et al. Arch Phys Med Rehabil. 2014 Nov;95(11):2000-5. doi: 10.1016/j.apmr.2014.06.020. Epub 2014 Jul 23. Arch Phys Med Rehabil. 2014. PMID: 25064777 Clinical Trial.
The participants in the MT group received 1 hour of MT in addition to the conventional stroke rehabilitation. MAIN OUTCOME MEASURES: The Upper Extremity Fugl-Meyer Assessment for motor recovery, Brunnstrom stages of motor recovery for the arm and hand, Box and Block Test f …
The participants in the MT group received 1 hour of MT in addition to the conventional stroke rehabilitation. MAIN OUTCOME MEASURES: The Upp …
Electric Field Navigated 1-Hz rTMS for Poststroke Motor Recovery: The E-FIT Randomized Controlled Trial.
Edwards DJ, Liu CY, Dunning K, Fregni F, Laine J, Leiby BE, Rogers LM, Harvey RL. Edwards DJ, et al. Stroke. 2023 Sep;54(9):2254-2264. doi: 10.1161/STROKEAHA.123.043164. Epub 2023 Aug 14. Stroke. 2023. PMID: 37577801 Free PMC article. Clinical Trial.
Outcomes measured 1 week, and 1, 3, and 6 months after the end of treatment included the following: upper extremity Fugl-Meyer (primary, 6 months after end of treatment), Action Research Arm Test, National Institutes of Health Stroke Scale, quality of life (EQ-5D), …
Outcomes measured 1 week, and 1, 3, and 6 months after the end of treatment included the following: upper extremity Fugl-Meyer (prima …
Do comorbid self-reported depression and anxiety influence outcomes following surgery for cervical spondylotic myelopathy?
Chan AK, Shaffrey CI, Park C, Gottfried ON, Than KD, Bisson EF, Bydon M, Asher AL, Coric D, Potts EA, Foley KT, Wang MY, Fu KM, Virk MS, Knightly JJ, Meyer S, Park P, Upadhyaya CD, Shaffrey ME, Buchholz AL, Tumialán LM, Turner JD, Michalopoulos GD, Sherrod BA, Agarwal N, Chou D, Haid RW, Mummaneni PV. Chan AK, et al. J Neurosurg Spine. 2023 Mar 31;39(1):11-27. doi: 10.3171/2023.2.SPINE22685. Print 2023 Jul 1. J Neurosurg Spine. 2023. PMID: 37021762
Preoperatively, patients with either SRD or SRA alone had worse scores for VAS neck pain (5.6 3.1 vs 5.1 3.3, p = 0.03), NDI (41.0 19.3 vs 36.8 20.8, p = 0.007), EQ-VAS (57.0 21.0 vs 60.7 21.7, p = 0.03), and EQ-5D (0.53 0.23 vs 0.58 0.21, p = 0.008) than patients without …
Preoperatively, patients with either SRD or SRA alone had worse scores for VAS neck pain (5.6 3.1 vs 5.1 3.3, p = 0.03), NDI (41.0 19.3 vs 3 …
Registry for Evaluating Healthy Life Expectancy and Long-Term Outcomes after Catheter Ablation of Atrial Fibrillation in the Very Elderly (REHEALTH AF) study: rationale and design of a prospective, multicentre, observational, comparative study.
Okumura Y, Nagashima K, Watanabe R, Yokoyama K, Kato T, Fukaya H, Hayashi H, Nakahara S, Shimizu W, Iwasaki YK, Fujimoto Y, Mukai Y, Ejima K, Otsuka T, Suzuki S, Murakami M, Kimura M, Harada M, Koyama J, Okamatsu H, Yamane T, Yamashita S, Tokuda M, Narui R, Takami M, Shoda M, Harada T, Nakajima I, Fujiu K, Hiroshima K, Tanimoto K, Fujino T, Nakamura K, Kumagai K, Okada A, Kobayashi H, Hayashi T, Watari Y, Hatsuno M, Tachibana E, Iso K, Sonoda K, Aizawa Y, Chikata A, Sakagami S, Inoue M, Minamiguchi H, Makino N, Satomi K, Yazaki Y, Aoyagi H, Ichikawa M, Haruta H, Hiro T, Okubo K, Arima K, Tojo T, Kihara H, Miyanaga S, Fukuda Y, Oiwa K, Fujiishi T, Akabane M, Ishikawa N, Kusano K, Miyamoto K, Tabuchi H, Shiozawa T, Miyamoto K, Mase H, Murotani K; REHEALTH AF study. Okumura Y, et al. BMJ Open. 2023 Feb 15;13(2):e068894. doi: 10.1136/bmjopen-2022-068894. BMJ Open. 2023. PMID: 36792334 Free PMC article.
We will collect standard clinical background information plus each patient's Clinical Frailty Scale score, AF-related symptoms, QoL (Five-Level Version of EQ-5D) scores, Mini-Mental State Examination (optional) score and laboratory test results, including measures of nutri …
We will collect standard clinical background information plus each patient's Clinical Frailty Scale score, AF-related symptoms, QoL (Five-Le …
Three Ways to Improve Arm Function in the Chronic Phase After Stroke by Robotic Priming Combined With Mirror Therapy, Arm Training, and Movement-Oriented Therapy.
Li YC, Lin KC, Chen CL, Yao G, Ya-Ju Chang, Lee YY, Liu CT, Chen WS. Li YC, et al. Arch Phys Med Rehabil. 2023 Aug;104(8):1195-1202. doi: 10.1016/j.apmr.2023.02.015. Epub 2023 Mar 16. Arch Phys Med Rehabil. 2023. PMID: 36933609 Clinical Trial.
INTERVENTIONS: Patients received 6 weeks of clinic-based R-mirr, R-bilat, or R-mov for 90 min/d, 3 d/wk, plus a transfer package at home for 5 d/wk. MAIN OUTCOME MEASURES: Fugl-Meyer Assessment Upper Extremity subscale (FMA-UE), ABILHAND, and Stroke Impact Scale v3.0 score …
INTERVENTIONS: Patients received 6 weeks of clinic-based R-mirr, R-bilat, or R-mov for 90 min/d, 3 d/wk, plus a transfer package at home for …
188 results